Abaloparatide

Overview

4.7 out of 5 (26 Reviews)

Credits

1.00

Post-Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

29 Jan 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6669 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7919 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$199 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$299 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Abaloparatide, a synthetic peptide analog of parathyroid hormone-related protein (PTHrP), is used to manage and treat osteoporosis. Osteoporosis is characterized by reduced bone mineral density due to changes in bone microstructure, resulting in an elevated risk of fractures. The US Food and Drug Administration (FDA) has approved abaloparatide use in postmenopausal women at high risk of fracture due to osteoporosis. In addition, abaloparatide is frequently prescribed for individuals who exhibit intolerance to or have not responded to conventional osteoporosis treatments.

In a double-blind, controlled, randomized phase II clinical trial, the safety and efficacy of abaloparatide demonstrated superiority in enhancing overall bone mineral density compared to teriparatide and placebo within these treatment groups. As osteoporosis primarily affects postmenopausal women, it is crucial to provide clinicians with essential knowledge about abaloparatide, which is vital to ensure optimal patient care and prevent disease progression. This activity reviews the indications, mechanism of action, administration, pharmacokinetics, and associated warnings related to abaloparatide. By enhancing the expertise of healthcare professionals with evidence-based strategies, this activity seeks to empower clinicians to incorporate abaloparatide into clinical practice seamlessly. This contribution aims to improve patient outcomes in the management of osteoporosis.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate candidates for abaloparatide therapy, considering postmenopausal women at high risk of fractures and those intolerant or unresponsive to traditional osteoporosis treatments.

  • Implement proper administration techniques, emphasizing subcutaneous injection and supplementing with calcium and vitamin D if dietary intake is inadequate.

  • Select appropriate dosages and durations of abaloparatide based on individual patient characteristics and response to treatment.

  • Collaborate with interprofessional healthcare teams, fostering a holistic approach to osteoporosis management, and seek specialist input when necessary.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Orthopaedic Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment Examination requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Himeshkumar P. on 11/6/2022

Holly J. on 12/12/2022

Li Mei L. on 12/16/2022

Larry M. on 12/16/2022

Brian C. on 12/31/2022

Sherilyn M. on 1/4/2023

Julie E. on 2/23/2023

John P. on 3/1/2023

Natalie M. on 7/3/2023

Allynda H. on 8/20/2023

Shalamar S. on 10/9/2023

A M. on 11/4/2023

William S. on 11/12/2023

Carlos L. on 12/9/2023

Drew H. on 12/5/2023

Tamara M. on 1/4/2024

Erika G. on 1/14/2024

Vivian S. on 1/20/2024

Julia L. on 1/21/2024

John L. on 2/8/2024

JEANNETTE A. on 3/24/2024

None

Khodaidad B. on 3/28/2024

Laura l. on 3/29/2024

MICHAEL DEV S. on 4/24/2024

Kenneth W. on 6/9/2024

Erica D. on 5/27/2024

1 of 5

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6669 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7919 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$199 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$299 per 1 year per user